Search the Newsroom
Filter By
Showing 121 - 130 of 2920 results
Children’s Hospital of Philadelphia Researchers Reveal Important Themes to Improve Interactions Between Police and Black Autistic Youth
Novel study emphasizes the need for improved training to recognize key behavior differences in this patient population
Children’s Hospital of Philadelphia, Stanford Researchers Reveal and Refine New Immunotherapy Platform with Increased Potential to Target Cancer Cells
TRACeR-I more accurately recognizes a wide variety of surface proteins expressed by cancer cells that make them easier to target with the body’s own immune system
Children’s Hospital of Philadelphia Researchers Develop Automated Tool for Integration and Analysis of Electronic Medical Record Data for Complex Rare Disease Patients
MMFP-Tableau offers a readily generalizable solution to make research and clinical electronic health system data more accessible and impactful.
A Heartfelt Haven: The 3 South Playroom Refresh
The 3 South Playroom in CHOP’s Main Building officially reopened after a renovation funded by generous support from Dancing While Cancering, the Maddie Kramer Foundation.
GAME CHANGER: How CHOP Has Elevated Pediatric Sports Medicine Care
Three pediatric sports medicine leaders from CHOP share perspectives about how youth athletes have changed, how the field has evolved, and predictions for the future.
Children’s Hospital of Philadelphia Researchers Find Precision Medicine Treatment Delivers Strong Results for Infantile Fibrosarcoma and Other Solid Tumors
Researchers at Children’s Hospital of Philadelphia (CHOP) and the Children’s Oncology Group (COG) found that larotrectinib, an oral drug that stops cancer-cell growth, was highly effective in pediatric patients with newly diagnosed infantile fibrosarcoma (IFS) or other solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation. The study, published today in the Journal of Clinical Oncology, is the first COG trial to test precision medicine in a front-line setting across all different types of solid tumors based on a genetic biomarker rather than histology. It is poised to redefine the approach to treatment for newly diagnosed fibrosarcoma and other solid tumors with the NTRK gene fusion, potentially reducing or eliminating the need for these patients to receive chemotherapy.
Children’s Hospital of Philadelphia Researchers Find Rotavirus Vaccine is Safe for Use in NICU Babies
Risk of transmission of the rotavirus vaccine is extremely low and poses very minimal risk to NICU babies
New Research from Children’s Hospital of Philadelphia to Transform Standard of Care Across the Globe for Newly Diagnosed Children with B-cell Acute Lymphoblastic Leukemia
Researchers at Children’s Hospital of Philadelphia (CHOP) and the Children’s Oncology Group (COG) announced the results of a Phase 3 study that demonstrated adding the bi-specific T-cell engager, blinatumomab, to chemotherapy for newly diagnosed National Cancer Institute (NCI) standard risk (SR) B-cell acute lymphoblastic leukemia (B-ALL) pediatric patients significantly improves survival outcomes. The results were published today in the New England Journal of Medicine and will be presented at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition on December 8.
A Swallowed Button Battery Is an Emergency
Button batteries, found in toys and remote controls, scales, lap tops and most electronic devices can cause injury or death if swallowed. Know what to do if this happens to your child.
The Melissa Ketunuti Basselier Prize in Global Child Health Inaugural Winner: Improving Children’s Lives Neighborhood by Neighborhood
In recognition of her impact on child health in Consuelo and beyond, Ramona Cordero was awarded the inaugural Melissa Ketunuti Basselier Prize in Global Child Health.